Go to main content
Harvard Business School
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions

Faculty & Research

  • HOME
  • FACULTY
  • RESEARCH
    • Global Research Centers
    • HBS Case Collection
    • HBS Case Development
    • Initiatives & Projects
    • Publications
    • Research Associate (RA) Positions
    • Research Services
    • Seminars & Conferences
    Close
  • FEATURED TOPICS
    • Business and Environment
    • Business History
    • Entrepreneurship
    • Finance
    • Globalization
    • Health Care
    • Human Behavior and Decision-Making
    • Leadership
    • Social Enterprise
    • Technology and Innovation
    Close
  • ACADEMIC UNITS
    • Accounting and Management
    • Business, Government and the International Economy
    • Entrepreneurial Management
    • Finance
    • General Management
    • Marketing
    • Negotiation, Organizations & Markets
    • Organizational Behavior
    • Strategy
    • Technology and Operations Management
    Close

Health Care

Page Content
Health Care is a featured research topic and an initiative at Harvard Business School.
 
Over the past several decades, HBS has built a foundation in health care research, from Clayton Christensen's application of disruptive innovations and Regina Herzlinger's concept of consumer-driven health care to Michael Porter's use of competitive strategy principles. Today our research focuses on 
  • how management principles and best practices from other industries can be applied;
  • how the process of innovation can be improved;
  • how principles of strategy and consumer choice can be utilized;
  • how information technology can expand access, decrease costs, and improve quality;
  • how new approaches in developing nations can impact global health.

Featured Works

  • Supplement | HBS Case Collection | February 2015

    The Affordable Care Act (A): Legislative Strategy in the House of Representatives

    Joseph L. Bower and Michael Norris

    In early 2009, the Obama administration and the Democratically-led Congress began working on what would eventually become the Affordable Care Act. The (A) case in this series discusses the legislative strategy in the House of Representatives, where three different committees each had jurisdiction over health care legislation.

    Keywords: health care; health care policy; Government and Politics; Government Administration; Health Care and Treatment; Health Industry; United States;

    Citation:

    Bower, Joseph L., and Michael Norris. "The Affordable Care Act (A): Legislative Strategy in the House of Representatives." Harvard Business School Supplement 315-032, February 2015.  View Details
    CiteView DetailsPurchaseRelated
  • Blog Post | Health Affairs Blog

    Innovation in Health Care Education: A Call to Action

    Regina E. Herzlinger, Vasant Kumar, Kevin Schulman and Karen Staman

    Health care administration educators are at a crossroads: the health care sector is rife with inefficiencies, erratic quality, unequal access, and sky-high costs, complex problems which call for innovative solutions, and yet, according to our content analysis of top U.S. health administration schools and a recent article in the Lancet, our educational systems focus their curricula on isolated,theoretical subjects, such as analytics and quantitative problem solving, rather than the team-oriented, practical problem-solving skills required for innovation. All too often, when graduates of these programs enter the workforce, they find themselves unequipped to meet the challenges for innovation of 21st century health care.

    Keywords: health care; health care education; Education; Health; Health Care and Treatment; Health Industry; Education Industry;

    Citation:

    Herzlinger, Regina E., Vasant Kumar, Kevin Schulman, and Karen Staman. "Innovation in Health Care Education: A Call to Action." Health Affairs Blog (January 29, 2015). http://healthaffairs.org/blog/2015/01/29/innovation-in-health-care-education-a-call-to-action/.  View Details
    CiteView Details Read Now Related
  • Article | Journal of Public Economics | December 2014

    No Margin, No Mission? A Field Experiment on Incentives for Public Services Delivery

    Nava Ashraf, Oriana Bandiera and B. Kelsey Jack

    A substantial body of research investigates the effect of pay for performance in firms, yet less is known about the effect of non-financial rewards, especially in organizations that hire individuals to perform tasks with positive social spillovers. We conduct a field experiment in which agents recruited by a public health organization to sell condoms are randomly allocated to four groups. Agents in the control group are hired as volunteers, whereas agents in the three treatment groups receive, respectively, a small monetary margin on each pack sold, a large margin, and a non-financial reward. The analysis yields three main findings. First, non-financial rewards are more effective at eliciting effort than either financial rewards or the volunteer contract and are also the most cost-effective of the four schemes. Second, non-financial rewards leverage intrinsic motivation and, contrary to existing laboratory evidence, financial incentives do not appear to crowd it out. Third, the responses to both types of incentives are stronger when their relative value is higher. Indeed, financial rewards are effective at motivating the poorest agents, and non-financial rewards are more effective when the peer group is larger. Overall, the findings demonstrate the power of non-financial rewards to motivate agents in settings where there are limits to the use of financial incentives.

    Keywords: incentives; non-monetary rewards; intrinsic motivation; Motivation and Incentives; Employees; Service Industry; Health Industry;

    Citation:

    Ashraf, Nava, Oriana Bandiera, and B. Kelsey Jack. "No Margin, No Mission? A Field Experiment on Incentives for Public Services Delivery." Journal of Public Economics 120 (December 2014): 1–17.  View Details
    CiteView DetailsFind at Harvard Read Now Related
  • Case | HBS Case Collection | August 2001 (Revised January 2015)

    SonoSite: A View Inside

    Clayton Christensen and Jeremy Dann

    After its spin-off from one of the world's largest ultrasound makers, Sonosite attempts to popularize a new kind of handheld ultrasound units. Sonosite needs to decide if it should focus on new markets that will value the portability and ease of use of its products, or if it should evolve its offerings so that they appeal to radiologists and cardiologists, the largest purchasers of ultrasound systems.

    Keywords: Customers; Disruptive Innovation; Product Positioning; Demand and Consumers;

    Citation:

    Christensen, Clayton, and Jeremy Dann. "SonoSite: A View Inside." Harvard Business School Case 602-056, August 2001. (Revised January 2015.)  View Details
    CiteView DetailsEducatorsPurchaseRelated
  • Case | HBS Case Collection | March 2014 (Revised December 2014)

    Vision 2020: Takeda and the Vaccine Business

    John A. Quelch and Margaret L. Rodriguez

    In 2014, Yasuchika Hasegawa was orchestrating the transformation of Takeda from a Japanese pharmaceutical company with a global footprint into a global company with a Japanese heritage. A 33-year veteran of Takeda, Hasegawa-san was appointed president of Takeda in 2003 and chief executive in 2009. By 2013, Takeda was in the midst of implementing its new Vision 2020 plan, a strategic plan for the evolving global corporation, which included developing a global vaccine business.

    Keywords: health care; global; NGO; public health; pharmaceutical industry; Japan; GSK; vaccine; supply chain; Market entry; Health; Health Care and Treatment; Trade; Market Entry and Exit; Global Strategy; Health Industry; Pharmaceutical Industry;

    Citation:

    Quelch, John A., and Margaret L. Rodriguez. "Vision 2020: Takeda and the Vaccine Business." Harvard Business School Case 514-084, March 2014. (Revised December 2014.)  View Details
    CiteView DetailsEducatorsPurchaseRelated
  • Case | HBS Case Collection | August 2015 (Revised August 2015)

    Hoag Orthopedic Institute

    Robert S. Kaplan and Jonathan Warsh

    Two groups of orthopedic surgeons form a joint venture with a community hospital to establish Hoag Orthopedic Institute, a for-profit hospital and two ambulatory service centers. By controlling and integrating all aspects of the patients' medical treatment, the physicians deliver superior outcomes, which they communicate with an annual public outcomes report. They also introduce bundled payment contracts with three insurers for orthopedic surgeries, and join a multi-hospital study for applying time-driven activity-based costing to identify process improvement and cost reduction opportunities. The case concludes with HOI leaders examining several options for expansion and growth.

    Keywords: outcomes measurement; bundled payment; health care; competitive strategy; activity-based costing and management; measurement and metrics; Measurement and Metrics; Activity Based Costing and Management; Competitive Strategy; Medical Specialties; Health Care and Treatment; Outcome or Result; Health Industry;

    Citation:

    Kaplan, Robert S., and Jonathan Warsh. "Hoag Orthopedic Institute." Harvard Business School Case 115-023, August 2015. (Revised August 2015.)  View Details
    CiteView DetailsEducatorsPurchaseRelated
  • Recent Publications
 
  1. Case | HBS Case Collection | February 2019

    Extend Fertility: Conceiving the Market for Egg Preservation (A)

    Debora L. Spar and Olivia Hull

    In April 2003, entrepreneur and MBA student Christy Jones was planning a new venture to help women preserve their fertility. Her company, Extend Fertility, would commercialize a technique known as egg freezing, in which a woman’s eggs were extracted and stored at low temperatures until she was ready to become a mother. To date, the emerging technology had mostly been used to preserve the fertility of cancer patients whose treatment course could damage their eggs. Jones’s business would target a massively broader population: healthy women wishing to postpone motherhood. Before Jones could launch Extend Fertility, she needed to answer two pressing questions. What, exactly, would an egg-freezing service be selling? And to whom?

    Keywords: Assisted reproduction; gender; strategy; entrepreneur; health and wellness; fertility; infertility; Women's health; Creating markets; egg freezing; fertility clinic; Strategy; Demographics; Entrepreneurship; Health Care and Treatment; Innovation and Invention; Marketing; Science; Technology; Innovation Strategy; Technological Innovation; Commercialization; Science-Based Business; Marketing Strategy; Business Plan; Product Marketing; Product Launch; Product Positioning; Mission and Purpose; Personal Development and Career; Social Issues; Integration; Health; Ethics; Health Industry; United States;

    Citation:

    Spar, Debora L., and Olivia Hull. "Extend Fertility: Conceiving the Market for Egg Preservation (A)." Harvard Business School Case 719-019, February 2019.  View Details
    CiteView DetailsEducatorsRelated
  2. Article | American Economic Journal: Economic Policy | February 2019

    Does It Matter if Your Health Insurer Is For Profit? Effects of Ownership on Premiums, Insurance Coverage, and Medical Spending

    Leemore S. Dafny

    There is limited empirical evidence about the impact of for-profit health insurers on various outcomes. I study the effects of conversions to for-profit status by Blue Cross Blue Shield (BCBS) affiliates in 11 states, spanning 28 geographic markets. I find both the BCBS affiliate and its rivals increased premiums following conversions in markets where the converting affiliate had substantial market share. Medicaid enrollment rates also increased in these markets, a pattern consistent with "crowd in" of families who were formerly privately insured. The results suggest for-profit insurers are likelier than not-for-profit insurers to exercise market power when they possess it.

    Keywords: health insurance; medical loss ratio; Blue Cross; Corporate Governance; Health; Insurance; For-Profit Firms; Insurance Industry; United States;

    Citation:

    Dafny, Leemore S. "Does It Matter if Your Health Insurer Is For Profit? Effects of Ownership on Premiums, Insurance Coverage, and Medical Spending." American Economic Journal: Economic Policy 11, no. 1 (February 2019): 222–265.  View Details
    CiteView DetailsFind at Harvard Read Now Related
  3. Article | Health Affairs

    Decreases In Readmissions Credited to Medicare's Program to Reduce Hospital Readmissions Have Been Overstated

    Christopher Ody, Lucy Msall, Leemore S. Dafny, David Grabowski and David Cutler

    Medicare’s Hospital Readmissions Reduction Program (HRRP) has been credited with lowering risk-adjusted readmission rates for targeted conditions at general acute care hospitals. However, these reductions appear to be illusory or overstated. This is because a concurrent change in electronic transaction standards allowed hospitals to document a larger number of diagnoses per claim, which had the effect of reducing risk-adjusted patient readmission rates. Prior studies of the HRRP relied upon control groups’ having lower baseline readmission rates, which could falsely create the appearance that readmission rates are changing more in the treatment than in the control group. Accounting for the revised standards reduced the decline in risk-adjusted readmission rates for targeted conditions by 48 percent. After further adjusting for differences in pre-HRRP readmission rates across samples, we found that declines for targeted conditions at general acute care hospitals were statistically indistinguishable from declines in two control samples. Either the HRRP had no effect on readmissions, or it led to a system-wide reduction in readmissions that was roughly half as large as prior estimates have suggested.

    Keywords: readmission rates; Hospitals; acute care hospitals; Medicare; myocardial infarction; heart failure; Health Care and Treatment;

    Citation:

    Ody, Christopher, Lucy Msall, Leemore S. Dafny, David Grabowski, and David Cutler. "Decreases In Readmissions Credited to Medicare's Program to Reduce Hospital Readmissions Have Been Overstated." Health Affairs 38, no. 1 (January 2019): 36–43.  View Details
    CiteView DetailsFind at HarvardPurchaseRelated
  4. Case | HBS Case Collection | December 2018 (Revised December 2018)

    Associação Saúde Criança: Trying to Break the Cycle of Poverty and Illness at Scale

    Julie Battilana, Marissa Kimsey, Priscilla Zogbi and Johanna Mair

    Dr. Vera Cordeiro founded the NGO Associação Saúde Criança in 1991 to try to help poor families break the cycle of poverty and illness in Brazil. She and her team of employees and volunteers developed a holistic methodology to address the multidimensional sources of poverty based on the pillars of health, housing, citizenship, income, and education. After introducing the seeds of this approach, the case examines the evolution of the organization’s attempts to grow its social impact in Brazil and beyond—including a loose network of sister organizations, social franchising, licensing agreements, and government adoption.

    Keywords: social innovation; NGO; scaling; health; Social Enterprise; Social Entrepreneurship; Non-Governmental Organizations; Health Care and Treatment; Poverty; Health Industry; South America; Brazil;

    Citation:

    Battilana, Julie, Marissa Kimsey, Priscilla Zogbi, and Johanna Mair. "Associação Saúde Criança: Trying to Break the Cycle of Poverty and Illness at Scale." Harvard Business School Case 419-048, December 2018. (Revised December 2018.)  View Details
    CiteView DetailsEducatorsRelated
  5. Article | NEJM Catalyst | November 8, 2018

    Transitioning Payment Models: Fee-for-Service to Value-Based Care

    Thomas W. Feeley and Namita Seth Mohta

    In a survey of the NEJM Catalyst Insights Council in July 2018, 42% of respondents say they think value-based reimbursement models will be the primary revenue model for U.S. health care. Indeed, this transition is already happening. Respondents report that a quarter of reimbursement at their organizations is based on value, on average. While three-quarters of their revenue remains fee-for-service, we see a remarkable change to a reimbursement system that was static for decades. In particular, survey respondents’ organizations are pursuing two value-based strategies: accountable care organizations, which often use capitated payments, and bundled payments. Nearly half (46%) of respondents say value-based contracts significantly improve the quality of care, and another 42% say value-based contracts significantly lower the cost of care. The survey identifies the leading barriers to implementing value-based reimbursement models. Infrastructure requirements, including information technology (indicated by 42% of respondents), and changing regulation/policy (34%) are the top two. There is strong consensus on the broad metrics that are most important for measuring value-based care. Outcome measures top the list, with 60% of respondents saying they are extremely important. This survey suggests that many in health care see value-based reimbursement as a real solution to the nation’s current health care crisis.

    Keywords: payment methods; value-based healthcare reimbursements; Health Care and Treatment; Value; Transformation;

    Citation:

    Feeley, Thomas W., and Namita Seth Mohta. "Transitioning Payment Models: Fee-for-Service to Value-Based Care." NEJM Catalyst (November 8, 2018).  View Details
    CiteView Details Read Now Related
  6. Case | HBS Case Collection | November 2018

    David Hysong and SHEPHERD Therapeutics

    Ananth Raman, John Masko and Aldo Sesia

    In 2016, David Hysong, at age 27, found out he had a rare, incurable cancer. Rather than wait around to die, Hysong, a recent graduate of Harvard Divinity School, decided to launch a biotechnology company called Shepherd Therapeutics to development treatments for his’ and other rare cancers. Two years later, the company had several drugs in promising stages of development but were at least 3 to 5 years away from commercialization, if they made it through clinical trials successfully. Only about 4% of drugs that enter clinical trials receive U.S. FDA approval. It is October 2018, and Shepherd is running out of money. Hysong needs to raise $5 million to fund operations for 2019 and at least $20 million for the following few years. But the company is too early to attract the type of venture capital he needs. Even if he got financing, Hysong worried that the company’s mission could be compromised by investors more interested in a return on their investment than saving lives, and he worried about the scaling challenges ahead.

    Keywords: cancer; therapeutics; drugs; Health Care and Treatment; Business Startups; Product Development; Financing and Loans; Growth and Development Strategy; Problems and Challenges;

    Citation:

    Raman, Ananth, John Masko, and Aldo Sesia. "David Hysong and SHEPHERD Therapeutics." Harvard Business School Case 619-012, November 2018.  View Details
    CiteView DetailsEducatorsRelated
  7. Article | Journal of the American College of Cardiology

    Operational Efficiency and Effective Management in the Catheterization Laboratory

    Grant W. Reed, Michael L. Tushman and Samir R. Kapadia

    Operational efficiency is a core business principle in which organizations strive to deliver high-quality goods or services in a cost-effective manner. This concept has become increasingly relevant to cardiac catheterization laboratories, as insurers move away from fee-for-service reimbursement and toward payment determined by quality measures bundled per episode of care. Accordingly, this review provides a framework for optimizing efficiency in the cardiac cath lab. The authors outline a management method based on the Nadler-Tushman Congruence Model, a commonly used business tool by which a company can assess whether its key elements are aligned with its strategy. Standardized metrics of cath lab efficiency are proposed, which can be used in public reports on this topic moving forward. Attention is paid to understanding balance sheets to track the financial health of the cath lab. Specific cost-saving measures are described, and examples of strategies used to save supply expenses are provided.

    Keywords: cath lab; catheterization laboratory; Health Care and Treatment; Performance Efficiency; Management; Performance Productivity; Cost Management; Health Industry;

    Citation:

    Reed, Grant W., Michael L. Tushman, and Samir R. Kapadia. "Operational Efficiency and Effective Management in the Catheterization Laboratory." Journal of the American College of Cardiology 72, no. 20 (November 20, 2018): 2507–2517.  View Details
    CiteView DetailsFind at Harvard Read Now Related
  8. Chapter | Innovation Policy and the Economy, Volume 19 | 2018

    The Orphan Drug Act at 35: Observations and an Outlook for the Twenty-First Century

    Nicholas Bagley, Benjamin Berger, Amitabh Chandra, Craig Garthwaite and Ariel Dora Stern

    On the 35th anniversary of the adoption of the Orphan Drug Act (ODA), we describe the enormous changes in the markets for therapies for rare diseases that have emerged over recent decades. The most prominent example is the fact that the profit-maximizing price of new orphan drugs appears to be greater today than it was in 1983. All else being equal, this should reduce the threshold for research and development (R&D) investment in an economically viable product. Further, the small size of patient populations for orphan drugs, together with the increasing prevalence of biologics among orphan drugs, have created a set of natural monopoly-like markets in which firms face little competition, even after the end of formal periods of patent protection and market exclusivity. Additionally, the evolving technologies of drug development—in particular, the increasingly common use of auxiliary endpoints in clinical trials and the use of biomarkers for patient selection for treatment—now allow manufacturers to target smaller populations. Taken together, these changes raise doubts about whether the ODA encourages the development of products that otherwise would not have been brought to market—or whether, instead, it simply rewards the producers of inframarginal products. After presenting empirical support for our claims of an evolving marketplace, we discuss the tradeoffs associated with reshaping the ODA for the 21st century.

    Keywords: Health Care and Treatment; Laws and Statutes; Research and Development; Investment; Markets; Monopoly;

    Citation:

    Bagley, Nicholas, Benjamin Berger, Amitabh Chandra, Craig Garthwaite, and Ariel Dora Stern. "The Orphan Drug Act at 35: Observations and an Outlook for the Twenty-First Century." Chap. 4 in Innovation Policy and the Economy, Volume 19, edited by Josh Lerner and Scott Stern, 97–137. University of Chicago Press, 2018.  View Details
    CiteView DetailsFind at Harvard Register to Read Related
  9. Article | PLoS ONE | 2018

    Knowledge about Tuberculosis and Infection Prevention Behavior: A Nine City Longitudinal Study from India

    Sophie Huddart, Thomas Bossuroy, Vincent Pons, Siddhartha Baral, Madhukar Pai and Clara Delavallade

    Background
    Improving patients’ tuberculosis (TB) knowledge is a salient component of TB control strategies. Patient knowledge of TB may encourage infection prevention behaviors and improve treatment adherence. The purpose of this study is to examine how TB knowledge and infection prevention behaviors change over the course of treatment.
    Methods
    A matched patient-health worker dataset (n = 6,031) of publicly treated TB patients with NGO-provided treatment support health workers was compiled in nine Indian cities from March 2013 to September 2014. At the beginning and end of TB treatment, patients were asked about their knowledge of TB symptoms, transmission, and treatment and infection prevention behaviors.
    Results
    Patients beginning TB treatment (n = 3,424) demonstrated moderate knowledge of TB; 52.5% (50.8%, 54.2%) knew that cough was a symptom of TB and 67.2% (65.6%, 68.7%) knew that TB was communicable. Overall patient knowledge was significantly associated with literacy, education, and income, and was higher at the end of treatment than at the beginning (3.7%, CI: 3.02%, 4.47%). Infection prevention behaviors like covering a cough (63.4%, CI: 61.2%, 65.0%) and sleeping separately (19.3%, CI: 18.0%, 20.7%) were less prevalent. The age difference between patient and health worker as well as a shared language significantly predicted patient knowledge and adherence to infection prevention behaviors.
    Conclusions
    Social proximity between health worker and patients predicted greater knowledge and adherence to infection prevention behaviors but the latter rate remains undesirably low.

    Keywords: Health Disorders; Knowledge Dissemination; Behavior; India;

    Citation:

    Huddart, Sophie, Thomas Bossuroy, Vincent Pons, Siddhartha Baral, Madhukar Pai, and Clara Delavallade. "Knowledge about Tuberculosis and Infection Prevention Behavior: A Nine City Longitudinal Study from India." PLoS ONE 13, no. 10 (2018).  View Details
    CiteView Details Read Now Related
  10. Case | HBS Case Collection | October 2018

    Fundraising at St. Camillus Hospital

    Srikant M. Datar and Caitlin N. Bowler

    St. Camillus is a fictional non-profit hospital in rural Maine facing a serious budget deficit. As Director of Marketing, Victoria Stern is building a team to modernize the hospital fundraising efforts. An interview with a promising candidate, who is also a digital native, forces her to confront shifting attitudes toward issues of data and privacy across generations against the backdrop of continued cybercrime and data breaches within the healthcare industry. Students grapple with the tension between data as "useful" or private within an organization. In this context they explore the ethical issues they will face around data security and data governance in their roles as managers.

    Keywords: data analysis; data privacy; data governance; non-profit; health care; fundraising; data security; Data and Data Sets; Safety; Governance; Ethics; Health Care and Treatment;

    Citation:

    Datar, Srikant M., and Caitlin N. Bowler. "Fundraising at St. Camillus Hospital." Harvard Business School Case 119-027, October 2018.  View Details
    CiteView DetailsEducatorsPurchaseRelated
  11.  
See all faculty publications on Healthcare »
Photo
Thomas W. Feeley
Senior Fellow
 
Photo
Ariel D. Stern
Assistant Professor of Business Administration
Technology and Operations Management
 
Photo
Robert S. Huckman
Albert J. Weatherhead III Professor of Business Administration
Chair, MBA Required Curriculum
Technology and Operations Management
 
Photo
Amitabh Chandra
Henry and Allison McCance Professor of Business Administration
Technology and Operations Management
 
Photo
Leemore S. Dafny
Bruce V. Rauner Professor of Business Administration
General Management
 
Photo
Joel Goh
Visiting Scholar
Technology and Operations Management
 
Photo
Regina E. Herzlinger
Nancy R. McPherson Professor of Business Administration (Leave of Absence)
General Management
 
Photo
Michael E. Porter
Bishop William Lawrence University Professor
Strategy
 
Photo
John R. Wells
Professor of Management Practice
Strategy
 
Photo
Francesca Gino
Tandon Family Professor of Business Administration
Unit Head, Negotiation, Organizations & Markets
Negotiation, Organizations & Markets
 
Photo
Tarun Khanna
Jorge Paulo Lemann Professor
Strategy
 
Photo
Leslie K. John
Marvin Bower Associate Professor
Negotiation, Organizations & Markets
 
 

SEE ALL »

Page Content 2
Page Content 3

Initiatives & Projects

  • Health Care

    The Health Care Initiative serves as a gateway for health care research, educational programs, and collaboration across all sectors of the health care industry.

  • Social Enterprise

    The Social Enterprise Initiative at HBS applies innovative business practices and managerial disciplines to drive sustained, high-impact social change.

« PREV 1 of 2 NEXT »

Faculty

HBS Working Knowledge

Pic
How Cost Accounting is Improving Healthcare in Rural Haiti
re Robert S. Kaplan
The cost of healthcare in rural Haiti was found to vary widely, even inside the same health organization. A pioneering cost accounting system co-developed by Robert Kaplan was called in to determine
Pic
Women Heart Patients Have Better Survival Odds with Women Doctors
re Laura Huang
Roughly one in 66 women has a better chance of leaving the hospital alive if their doctor is also a woman, according to research by Laura Huang and colleagues.
How Does Product Liability Risk Affect Innovation? Evidence from Medical Implants
This analysis examines how a surge in liability risk faced by upstream suppliers of general purpose technologies (polymers) affected downstream innovation in implant technologies. Implant patenting d

More »

Harvard Business Publishing

Article
What Business Schools Can Learn from the Medical Profession
by Nitin Nohria
Case
Fundraising at St. Camillus Hospital
by Srikant M. Datar and Caitlin N. Bowler

More »

ǁ
Campus Map
Campus Map
Harvard Business School
Soldiers Field
Boston, MA 02163
→ Map & Directions
→ More Contact Information
→ More Contact Information
→ More Contact Information
→ More Contact Information
  • HBS Facebook
  • Alumni Facebook
  • Executive Education Facebook
  • Michael Porter Facebook
  • Working Knowledge Facebook
  • HBS Twitter
  • Executive Education Twitter
  • HBS Alumni Twitter
  • Michael Porter Twitter
  • Recruiting Twitter
  • Rock Center Twitter
  • Working Knowledge Twitter
  • Jobs Twitter
  • HBS Youtube
  • Michael Porter Youtube
  • Executive Education Youtube
  • HBS Linkedin
  • Alumni Linkedin
  • Executive Education Linkedin
  • MBA Linkedin
  • Linkedin
  • HBS Instagram
  • Alumni Instagram
  • Executive Education Instagram
  • Michael Porter Instagram
  • HBS iTunes
  • Executive Education iTunes
  • HBS Tumblr
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Accessibility
  • Privacy
  • Terms of Use
Copyright © President & Fellows of Harvard College